Publicacións en colaboración con investigadores/as de Università di Perugia (23)

2023

  1. Erratum to: Mapping the human genetic architecture of COVID-19 (Nature, (2021), 600, 7889, (472-477), 10.1038/s41586-021-03767-x)

    Nature

  2. Major in-hospital bleeding in patients with pulmonary embolism treated with systemic thrombolysis

    Thrombosis Research

  3. Revised Paradigm for Acute Pulmonary Embolism Prognostication and Treatment

    American journal of respiratory and critical care medicine, Vol. 208, Núm. 5, pp. 524-527

2021

  1. Mapping the human genetic architecture of COVID-19

    Nature, Vol. 600, Núm. 7889, pp. 472-477

  2. Right ventricle assessment in patients with pulmonary embolism at low risk for death based on clinical models: an individual patient data meta-analysis

    European heart journal, Vol. 42, Núm. 33, pp. 3190-3199

  3. Survival and quality of life after early discharge in low-risk pulmonary embolism

    European Respiratory Journal, Vol. 57, Núm. 2

2020

  1. 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European respiratory society (ERS)

    European Heart Journal, Vol. 41, Núm. 4, pp. 543-603

  2. ETNA VTE Europe: A contemporary snapshot of patients treated with edoxaban in clinical practice across eight European countries

    European Journal of Internal Medicine, Vol. 82, pp. 48-55

  3. ETNA-VTE Europe: Benefits and risks of venous thromboembolism treatment using edoxaban in the first 3 months

    Thrombosis Research, Vol. 196, pp. 297-304

  4. Early discharge and home treatment of patients with low-risk pulmonary embolism with the oral factor Xa inhibitor rivaroxaban: An international multicentre single-arm clinical trial

    European Heart Journal, Vol. 41, Núm. 4, pp. 509-518

2019

  1. 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS)

    European Respiratory Journal, Vol. 54, Núm. 3

  2. Health-related quality of life and mortality in patients with pulmonary embolism: a prospective cohort study in seven European countries

    Quality of Life Research, Vol. 28, Núm. 8, pp. 2111-2124

  3. Incomplete echocardiographic recovery at 6 months predicts long-term sequelae after intermediate-risk pulmonary embolism. A post-hoc analysis of the Pulmonary Embolism Thrombolysis (PEITHO) trial

    Clinical Research in Cardiology, Vol. 108, Núm. 7, pp. 772-778

2018

  1. Correction: Design and rationale of the non-interventional, edoxaban treatment in routiNe clinical prActice in patients with venous ThromboEmbolism in Europe (ETNA-VTE-Europe) study [Thrombosis Journal, 16, (2018) (9)] DOI: 10.1186/s12959-018-0163-7

    Thrombosis Journal

  2. Design and rationale of the non-interventional, edoxaban treatment in routiNe clinical prActice in patients with venous ThromboEmbolism in Europe (ETNA-VTE-Europe) study

    Thrombosis Journal, Vol. 16, Núm. 1

  3. Differential impact of syncope on the prognosis of patients with acute pulmonary embolism: A systematic review and meta-analysis

    European Heart Journal, Vol. 39, Núm. 47, pp. 4186-4195

  4. Pulmonary embolism in Europe - Burden of illness in relationship to healthcare resource utilization and return to work

    Thrombosis Research, Vol. 170, pp. 181-191

2017

  1. Impact of Thrombolytic Therapy on the Long-Term Outcome of Intermediate-Risk Pulmonary Embolism

    Journal of the American College of Cardiology, Vol. 69, Núm. 12, pp. 1536-1544

  2. Sex differences in the characteristics and short-term prognosis of patients presenting with acute symptomatic pulmonary embolism

    PLoS ONE, Vol. 12, Núm. 11

2016

  1. Home treatment of patients with low-risk pulmonary embolism with the oral factor Xa inhibitor rivaroxaban: Rationale and design of the HoT-PE Trial

    Thrombosis and Haemostasis, Vol. 116, Núm. 1, pp. 191-197